Clinical Trial Update: Value of ctDNA in the Treatment of Multiple Primary Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring the value of ctDNA in managing patients with multiple primary cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Primary Cancers

Snippet

Sponsor: Fudan University | Conditions: Multiple Primary Cancers | Phase 2 | Status: UNKNOWN